Chronic Prostatitis/Chronic Pelvic Pain as a Psycho-Neuromuscular Disorder-A Meta-analysis

To evaluate effectiveness of physical therapy, biofeedback, and/or cognitive behavioral therapy for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS). This symptom complex has resisted resolution from conventional urologic treatment of the prostate, which includes antibiotics, alpha-blockers, and analgesics. Beginning in 1995, a new paradigm was introduced viewing CP/CPPS as a psycho-neuromuscular disorder driven by protective pelvic floor guarding and psychosocial stress.

A literature search (PubMed, Google Scholar, and the Cochran Library) was conducted from inception through December 2017 using key words related to CP/CPPS (e.g., prostatitis, pelvic pain) with physical therapy (e.g., myofascial trigger point release) and/or biofeedback or cognitive behavioral treatment. Studies were required to include pre and post- treatment with the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) scores.

Eight studies inclusive of 280 patients met primary inclusion criteria. Study sample sizes ranged from 8 to 116 men (mean = 35); treatment duration ranged from 8 to 26 weeks (mean = 14). Pre-treatment mean CPSI scores ranged from 21.7 to 33.5. The non- standardized weighted mean reduction of CPSI score from baseline was 8.8 points; 95% CI (7.5, 11.1); p<0.001. The I2 statistic = 18.5% indicating little heterogeneity between studies. A sensitivity analysis including an additional multimodal intervention study of with 100 patients produced similar findings.

Conventional medical treatment often fails to resolve CP/CPPS. A 6-point reduction in CPSI score is considered a clinically meaningful improvement of symptoms. This meta-analysis shows that treating CP/CPPS as a psycho-neuromuscular disorder can significantly exceed this clinical threshold.

Urology. 2018 Jul 27 [Epub ahead of print]

Rodney U Anderson, David Wise, Brian H Nathanson

Stanford University School of Medicine Stanford, CA 94305. Electronic address: ., New Pelvic Pain Technologies, Inc. San Francisco, CA., OptiStatim, LLC, Longmeadow, MA.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe